DOCSLIB.ORG

Whole-Exome/Genome Sequencing and Genomics Abstract

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Whole-Exome/Genome Sequencing and Genomics Abstract SUPPLEMENT ARTICLE Whole-Exome/Genome Sequencing and Genomics AUTHORS: Wayne W. Grody, MD, PhD, FCAP, FACMG,a Barry H. Thompson, MD, MS, FAAP, FACMG,b and Louanne abstract c Hudgins, MD, FAAP, FACMG As medical genetics has progressed from a descriptive entity to one aDivisions of Medical Genetics and Molecular Pathology, focused on the functional relationship between genes and clinical dis- Departments of Pathology and Laboratory Medicine, Pediatrics, and Human Genetics, UCLA School of Medicine, Los Angeles, orders, emphasis has been placed on genomics. Genomics, a subelement California; bAmerican College of Medical Genomics and Genetics, of genetics, is the study of the genome, the sum total of all the genes of Bethesda, Maryland; and cDivision of Medical Genetics, an organism. The human genome, which is contained in the 23 pairs of Department of Pediatrics, Stanford University School of Medicine/Lucile Packard Children’s Hospital, Stanford, California nuclear chromosomes and in the mitochondrial DNA of each cell, com- prises .6 billion nucleotides of genetic code. There are some 23 000 KEY WORDS cytogenetics, genetic testing, genomics, next-generation protein-coding genes, a surprisingly small fraction of the total genetic sequencing, primary care, whole-exome sequencing, whole- material, with the remainder composed of noncoding DNA, regulatory genome sequencing sequences, and introns. The Human Genome Project, launched in ABBREVIATION 1990, produced a draft of the genome in 2001 and then a finished DTC—direct-to-consumer sequence in 2003, on the 50th anniversary of the initial publication of www.pediatrics.org/cgi/doi/10.1542/peds.2013-1032E Watson and Crick’s paper on the double-helical structure of DNA. Since doi:10.1542/peds.2013-1032E then, this mass of genetic information has been translated at an ever- Accepted for publication Aug 28, 2013 increasing pace into useable knowledge applicable to clinical medi- Address correspondence to Louanne Hudgins, MD, FAAP, FACMG, cine. The recent advent of massively parallel DNA sequencing (also Division of Medical Genetics, Department of Pediatrics, Stanford known as shotgun, high-throughput, and next-generation sequencing) University School of Medicine/Lucile Packard Children’s Hospital, 300 Pasteur Dr, H315, Stanford, CA 94305-5208. E-mail: has brought whole-genome analysis into the clinic for the first time, [email protected] and most of the current applications are directed at children with PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275). congenital conditions that are undiagnosable by using standard ge- Copyright © 2013 by the American Academy of Pediatrics netic tests for single-gene disorders. Thus, pediatricians must be- FINANCIAL DISCLOSURE: The authors have indicated they have come familiar with this technology, what it can and cannot offer, no financial relationships relevant to this article to disclose. and its technical and ethical challenges. Here, we address the con- FUNDING: This effort was supported by grant UC7MC21713 from cepts of human genomic analysis and its clinical applicability for the Health Resources and Services Administration’s Maternal primary care providers. Pediatrics 2013;132:S211–S215 and Child Health Bureau. The Genetics in Primary Care Institute is a cooperative agreement between the American Academy of Pediatrics and the Maternal and Child Health Bureau. POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose. PEDIATRICS Volume 132, Supplement 3, December 2013 S211 Downloaded from www.aappublications.org/news by guest on October 2, 2021 INTRODUCTION been enhanced by the development single genes, as we do in the current paper. Semantics aside, the ultimate The term “genetic testing” can encom- of molecular techniques, particularly fl goal of the field of genomics is to pass the detection and characteriza- uorescence in situ hybridization: the identify how mutations in multiple tion of any analyte that is determined useoflabeledDNAprobesthathybridize genes interact with each other and the or predicted by one’s inheritance. In the to intact chromosomes to reveal sub- environment, a goal that may not be broadest sense of the term, genetic microscopic deletions or duplications achieved for several years. testing includes, for example, mea- of a particular region of the genome. surements of cholesterol levels or Even more recently, chromosomal plasma metabolites such as amino microarrays, consisting of as many as 1 TECHNICAL ASPECTS OF DNA acids and microscopic examination of million DNA probes bound to a solid SEQUENCING support, have been used to interrogate a peripheral blood smear for sickle- For most of the .25-year history of shaped red cells or spherocytes. regions of the entire genome. This method is capable of detecting dele- clinical molecular diagnostics, and for These tests reflect the effects or signs the entire duration of the Human Ge- of genetic hyperlipidemias, errors of tions and duplications of chromosomal regions at much finer resolution than nome Project, DNA sequencing was amino acid metabolism, and hemolytic performed on semiautomated capil- afforded by standard karyotype. In fact, anemias, respectively. Such biochemical lary electrophoresis instruments by the power and diagnostic yield of genetic testing has been available for using the biochemical method known chromosomalmicroarraysaresomuch many decades. However, the most fun- as dideoxy-chain-termination, or Sanger greater that the American College of damental form of genetic testing clearly sequencing, after its inventor. This highly Medical Genetics and Genomics has is the direct analysis of the genetic accurate, although relatively slow, recommended that this test replace material itself (chromosomes, genes, method can provide the DNA sequence of karyotype analysis as the standard or the entire genome), which falls un- a targeted and limited region of 150 to first-tier test in the diagnostic evalua- der the domains of cytogenetics and 200 nucleotides in a single run of 1 to 2 tion of patients with congenital mal- molecular genetics. Biochemical ge- days. This length of DNA represents formations, nonspecific dysmorphic netics, cytogenetics, and molecular only a small fraction of the total length features, developmental delay/intellectual genetics are the 3 laboratory sub- of most genes, let alone the entire ge- disability, and autism.1 specialties recognized by the American nome, which explains why sequencing Board of Medical Genetics. Finally, a new technology called next- the first human genome took 13 years Theadventofclinicalcytogeneticsdates generation DNA sequencing has and cost approximately $3 billion. Ob- to 1959, with the discovery that children placed within reach the ultimate, most viously, an effort of that magnitude with Down syndrome have 47 chromo- fundamental, and highest-resolution could never remotely be translated into somes in their cells rather than the genetic analysis currently conceiv- a clinical test. able: the precise identification and or- normal 46, the abnormality being an One reason for the slow pace of Sanger extra copy of chromosome 21 (trisomy dering of all 6 billion nucleotides in the sequencing is that it is based on 21).Sincethattime,countlessdefectsin human genome. This technology, more daughter strand synthesis of a small chromosomal number, structure, and than any other, has opened the way to stretch of DNA that is selected by using position have been observed and as- true genomic medicine. the hybridization of specific oligonucle- sociated with various congenital (and It is important to point out some se- otide primers to just that region. The neoplastic) disorders. In a sense, chro- mantic distinctions related to the primers serve as start sites for mosomal analysis (also known as kar- evolving field of genomics. Most agree DNA polymerase to make complemen- yotype analysis) can be considered the that the term “genetics” refers to the tary strands that terminate whenever first genome-wide test because it study of single genes in isolation. Many a particular dideoxynucleotide de- includes all the nuclear genetic mate- refer to “genomics” as the study of all rivative is incorporated into the elon- rial of the cell. Such analysis is limited, genes in the genome and the inter- gating strand, and the resulting however, by the resolution of the light actions among them and their envi- sequence is deduced by measuring microscope; any deletion, duplication, ronments, as noted in the Executive the sizes of the terminated fragments insertion, or translocation that is too Summary. However, others use the on the capillary electrophoresis in- small to be observed under standard term “genomics” to describe whole- strument. In contrast, next-generation, magnification will go undetected. More exome and whole-genome sequenc- or massively parallel, sequencing recently, the field of cytogenetics has ing aimed at identifying mutations in breaks up the whole genome into .300 S212 GRODY et al Downloaded from www.aappublications.org/news by guest on October 2, 2021 SUPPLEMENT ARTICLE million small fragments, which are disorders are believed to be due to DIAGNOSIS AND DISCOVERY then universally primed for DNA poly- mutations in the coding regions, this THROUGH NEXT-GENERATION merase copying by using 4-color fluo- approach allows laboratories to focus SEQUENCING rescently labeled nucleotides and are exclusively on those regions and elim- Whether conducted by using a whole- analyzed on instruments
Load more

Recommended publications
  • Mobile Genetic Elements in Streptococci
    Curr. Issues Mol. Biol. (2019) 32: 123-166. DOI: https://dx.doi.org/10.21775/cimb.032.123 Mobile Genetic Elements in Streptococci Miao Lu#, Tao Gong#, Anqi Zhang, Boyu Tang, Jiamin Chen, Zhong Zhang, Yuqing Li*, Xuedong Zhou* State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China. #Miao Lu and Tao Gong contributed equally to this work. *Address correspondence to: [email protected], [email protected] Abstract Streptococci are a group of Gram-positive bacteria belonging to the family Streptococcaceae, which are responsible of multiple diseases. Some of these species can cause invasive infection that may result in life-threatening illness. Moreover, antibiotic-resistant bacteria are considerably increasing, thus imposing a global consideration. One of the main causes of this resistance is the horizontal gene transfer (HGT), associated to gene transfer agents including transposons, integrons, plasmids and bacteriophages. These agents, which are called mobile genetic elements (MGEs), encode proteins able to mediate DNA movements. This review briefly describes MGEs in streptococci, focusing on their structure and properties related to HGT and antibiotic resistance. caister.com/cimb 123 Curr. Issues Mol. Biol. (2019) Vol. 32 Mobile Genetic Elements Lu et al Introduction Streptococci are a group of Gram-positive bacteria widely distributed across human and animals. Unlike the Staphylococcus species, streptococci are catalase negative and are subclassified into the three subspecies alpha, beta and gamma according to the partial, complete or absent hemolysis induced, respectively. The beta hemolytic streptococci species are further classified by the cell wall carbohydrate composition (Lancefield, 1933) and according to human diseases in Lancefield groups A, B, C and G.
    [Show full text]
  • 13 Genomics and Bioinformatics
    Enderle / Introduction to Biomedical Engineering 2nd ed. Final Proof 5.2.2005 11:58am page 799 13 GENOMICS AND BIOINFORMATICS Spencer Muse, PhD Chapter Contents 13.1 Introduction 13.1.1 The Central Dogma: DNA to RNA to Protein 13.2 Core Laboratory Technologies 13.2.1 Gene Sequencing 13.2.2 Whole Genome Sequencing 13.2.3 Gene Expression 13.2.4 Polymorphisms 13.3 Core Bioinformatics Technologies 13.3.1 Genomics Databases 13.3.2 Sequence Alignment 13.3.3 Database Searching 13.3.4 Hidden Markov Models 13.3.5 Gene Prediction 13.3.6 Functional Annotation 13.3.7 Identifying Differentially Expressed Genes 13.3.8 Clustering Genes with Shared Expression Patterns 13.4 Conclusion Exercises Suggested Reading At the conclusion of this chapter, the reader will be able to: & Discuss the basic principles of molecular biology regarding genome science. & Describe the major types of data involved in genome projects, including technologies for collecting them. 799 Enderle / Introduction to Biomedical Engineering 2nd ed. Final Proof 5.2.2005 11:58am page 800 800 CHAPTER 13 GENOMICS AND BIOINFORMATICS & Describe practical applications and uses of genomic data. & Understand the major topics in the field of bioinformatics and DNA sequence analysis. & Use key bioinformatics databases and web resources. 13.1 INTRODUCTION In April 2003, sequencing of all three billion nucleotides in the human genome was declared complete. This landmark of modern science brought with it high hopes for the understanding and treatment of human genetic disorders. There is plenty of evidence to suggest that the hopes will become reality—1631 human genetic diseases are now associated with known DNA sequences, compared to the less than 100 that were known at the initiation of the Human Genome Project (HGP) in 1990.
    [Show full text]
  • Genomics and Its Impact on Science and Society: the Human Genome Project and Beyond
    DOE/SC-0083 Genomics and Its Impact on Science and Society The Human Genome Project and Beyond U.S. Department of Energy Genome Research Programs: genomics.energy.gov A Primer ells are the fundamental working units of every living system. All the instructions Cneeded to direct their activities are contained within the chemical DNA (deoxyribonucleic acid). DNA from all organisms is made up of the same chemical and physical components. The DNA sequence is the particular side-by-side arrangement of bases along the DNA strand (e.g., ATTCCGGA). This order spells out the exact instruc- tions required to create a particular organism with protein complex its own unique traits. The genome is an organism’s complete set of DNA. Genomes vary widely in size: The smallest known genome for a free-living organism (a bac- terium) contains about 600,000 DNA base pairs, while human and mouse genomes have some From Genes to Proteins 3 billion (see p. 3). Except for mature red blood cells, all human cells contain a complete genome. Although genes get a lot of attention, the proteins DNA in each human cell is packaged into 46 chro- perform most life functions and even comprise the mosomes arranged into 23 pairs. Each chromosome is majority of cellular structures. Proteins are large, complex a physically separate molecule of DNA that ranges in molecules made up of chains of small chemical com- length from about 50 million to 250 million base pairs. pounds called amino acids. Chemical properties that A few types of major chromosomal abnormalities, distinguish the 20 different amino acids cause the including missing or extra copies or gross breaks and protein chains to fold up into specific three-dimensional rejoinings (translocations), can be detected by micro- structures that define their particular functions in the cell.
    [Show full text]
  • Genetic Effects on Microsatellite Diversity in Wild Emmer Wheat (Triticum Dicoccoides) at the Yehudiyya Microsite, Israel
    Heredity (2003) 90, 150–156 & 2003 Nature Publishing Group All rights reserved 0018-067X/03 $25.00 www.nature.com/hdy Genetic effects on microsatellite diversity in wild emmer wheat (Triticum dicoccoides) at the Yehudiyya microsite, Israel Y-C Li1,3, T Fahima1,MSRo¨der2, VM Kirzhner1, A Beiles1, AB Korol1 and E Nevo1 1Institute of Evolution, University of Haifa, Mount Carmel, Haifa 31905, Israel; 2Institute for Plant Genetics and Crop Plant Research, Corrensstrasse 3, 06466 Gatersleben, Germany This study investigated allele size constraints and clustering, diversity. Genome B appeared to have a larger average and genetic effects on microsatellite (simple sequence repeat number (ARN), but lower variance in repeat number 2 repeat, SSR) diversity at 28 loci comprising seven types of (sARN), and smaller number of alleles per locus than genome tandem repeated dinucleotide motifs in a natural population A. SSRs with compound motifs showed larger ARN than of wild emmer wheat, Triticum dicoccoides, from a shade vs those with perfect motifs. The effects of replication slippage sun microsite in Yehudiyya, northeast of the Sea of Galilee, and recombinational effects (eg, unequal crossing over) on Israel. It was found that allele distribution at SSR loci is SSR diversity varied with SSR motifs. Ecological stresses clustered and constrained with lower or higher boundary. (sun vs shade) may affect mutational mechanisms, influen- This may imply that SSR have functional significance and cing the level of SSR diversity by both processes. natural constraints.
    [Show full text]
  • Gene Prediction and Genome Annotation
    A Crash Course in Gene and Genome Annotation Lieven Sterck, Bioinformatics & Systems Biology VIB-UGent [email protected] ProCoGen Dissemination Workshop, Riga, 5 nov 2013 “Conifer sequencing: basic concepts in conifer genomics” “This Project is financially supported by the European Commission under the 7th Framework Programme” Genome annotation: finding the biological relevant features on a raw genomic sequence (in a high throughput manner) ProCoGen Dissemination Workshop, Riga, 5 nov 2013 Thx to: BSB - annotation team • Lieven Sterck (Ectocarpus, higher plants, conifers, … ) • Yao-cheng Lin (Fungi, conifers, …) • Stephane Rombauts (green alga, mites, …) • Bram Verhelst (green algae) • Pierre Rouzé • Yves Van de Peer ProCoGen Dissemination Workshop, Riga, 5 nov 2013 Annotation experience • Plant genomes : A.thaliana & relatives (e.g. A.lyrata), Poplar, Physcomitrella patens, Medicago, Tomato, Vitis, Apple, Eucalyptus, Zostera, Spruce, Oak, Orchids … • Fungal genomes: Laccaria bicolor, Melampsora laricis- populina, Heterobasidion, other basidiomycetes, Glomus intraradices, Pichia pastoris, Geotrichum Candidum, Candida ... • Algal genomes: Ostreococcus spp, Micromonas, Bathycoccus, Phaeodactylum (and other diatoms), E.hux, Ectocarpus, Amoebophrya … • Animal genomes: Tetranychus urticae, Brevipalpus spp (mites), ... ProCoGen Dissemination Workshop, Riga, 5 nov 2013 Why genome annotation? • Raw sequence data is not useful for most biologists • To be meaningful to them it has to be converted into biological significant knowledge
    [Show full text]
  • Whole Exome and Whole Genome Sequencing – Oxford Clinical Policy
    UnitedHealthcare® Oxford Clinical Policy Whole Exome and Whole Genome Sequencing Policy Number: LABORATORY 024.11 T2 Effective Date: October 1, 2021 Instructions for Use Table of Contents Page Related Policies Coverage Rationale ....................................................................... 1 Chromosome Microarray Testing (Non-Oncology Documentation Requirements ...................................................... 2 Conditions) Definitions ...................................................................................... 2 Molecular Oncology Testing for Cancer Diagnosis, Prior Authorization Requirements ................................................ 3 Prognosis, and Treatment Decisions Applicable Codes .......................................................................... 3 • Preimplantation Genetic Testing Description of Services ................................................................. 4 Clinical Evidence ........................................................................... 4 U.S. Food and Drug Administration ........................................... 22 References ................................................................................... 22 Policy History/Revision Information ........................................... 26 Instructions for Use ..................................................................... 27 Coverage Rationale Whole Exome Sequencing (WES) Whole Exome Sequencing (WES) is proven and Medically Necessary for the following: • Diagnosing or evaluating a genetic disorder
    [Show full text]
  • Small Variants Frequently Asked Questions (FAQ) Updated September 2011
    Small Variants Frequently Asked Questions (FAQ) Updated September 2011 Summary Information for each Genome .......................................................................................................... 3 How does Complete Genomics map reads and call variations? ........................................................................... 3 How do I assess the quality of a genome produced by Complete Genomics?................................................ 4 What is the difference between “Gross mapping yield” and “Both arms mapped yield” in the summary file? ............................................................................................................................................................................. 5 What are the definitions for Fully Called, Partially Called, Half-Called and No-Called?............................ 5 In the summary-[ASM-ID].tsv file, how is the number of homozygous SNPs calculated? ......................... 5 In the summary-[ASM-ID].tsv file, how is the number of heterozygous SNPs calculated? ....................... 5 In the summary-[ASM-ID].tsv file, how is the total number of SNPs calculated? .......................................... 5 In the summary-[ASM-ID].tsv file, what regions of the genome are included in the “exome”? .............. 6 In the summary-[ASM-ID].tsv file, how is the number of SNPs in the exome calculated? ......................... 6 In the summary-[ASM-ID].tsv file, how are variations in potentially redundant regions of the genome counted? .....................................................................................................................................................................
    [Show full text]
  • Whole Exome Sequencing Faqs
    WHOLE EXOME SEQUENCING (WES) Whole Exome Sequencing (WES) is generally ordered when a patient’s medical history and physical exam strongly suggest that there is an underlying genetic etiology. In some cases, the patient may have had an extensive evaluation consisting of multiple genetic tests, without identifying an etiology. In other cases, a physician may opt to order one of the Whole Exome Sequencing tests early in the patient’s evaluation in an effort to expedite a possible diagnosis and reduce costs incurred by multiple tests. Whole Exome Sequencing is a highly complex test that is newly developed for the identification of changes in a patient’s DNA that are causative or related to their medical concerns. In contrast to current sequencing tests that analyze one gene or small groups of related genes at a time, Whole Exome Sequencing analyzes the exons or coding regions of thousands of genes simultaneously using next-generation sequencing techniques. The exome refers to the portion of the human genome that contains functionally important sequences of DNA that direct the body to make proteins essential for the body to function properly. These regions of DNA are referred to as exons. There are approximately 180,000 exons in the human genome which represents about 3% of the genome. These 180,000 exons are arranged in about 22,000 genes. It is known that many of the errors that occur in DNA sequences that then lead to genetic disorders are located in the exons. Therefore, sequencing of the exome is thought to be an efficient method of analyzing a patient’s DNA to discover the genetic cause of diseases or disabilities.
    [Show full text]
  • From the Human Genome Project to Genomic Medicine a Journey to Advance Human Health
    From the Human Genome Project to Genomic Medicine A Journey to Advance Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Origin of “Genomics”: 1987 Genomics (1987) “For the newly developing discipline of [genome] mapping/sequencing (including the analysis of the information), we have adopted the term GENOMICS… ‘The Genome Institute’ Office for Human Genome Research 1988-1989 National Center for Human Genome Research 1989-1997 National Human Genome Research Institute 1997-present NHGRI: Circa 1990-2003 Human Genome Project NHGRI Today: Characteristic Features . Relatively young (~28 years) . Relatively small (~1.7% of NIH) . Unusual historical origins (think ‘Human Genome Project’) . Emphasis on ‘Team Science’ (think managed ‘consortia’) . Rapidly disseminating footprint (think ‘genomics’) . Novel societal/bioethics research component (think ‘ELSI’) . Over-achievers for trans-NIH initiatives (think ‘Common Fund’) . Vibrant (and large) Intramural Research Program A Quarter Century of Genomics Human Genome Sequenced for First Time by the Human Genome Project Genomic Medicine An emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision- making) and the other implications of that clinical use The Path to Genomic Medicine ? Human Realization of Genome Genomic Project Medicine Nature Nature Base Pairs to Bedside 2003 Heli201x to 1Health A Quarter Century of Genomics Human Genome Sequenced for First Time by the Human Genome Project
    [Show full text]
  • A Study of Visitors to Genome: the Secret of How Life Works
    A STUDY OF VISITORS TO GENOME: THE SECRET OF HOW LIFE WORKS March 2004 Office of Policy and Analysis Washington, DC 20560-0405 Office of Policy and Analysis Study Team Ioana Munteanu Andrew Pekarik Whitney Watriss FOREWORD This study of Genome: The Secret of How Life Works focuses on visitors’ perceptions of the exhibition. It draws attention to interactive aspects of the exhibition as well as to underlying conceptual dimensions: basic genome science and applied genome science. To produce information on the success of the exhibition, it captures responses to key factors in the exhibit, such as visitor satisfaction with respect to interactive activities and visitor satisfaction concerning physical attributes and explores the relationships among these factors through correlational analysis. The study was designed and administered by Ioana Munteanu, who analyzed the data and wrote this report; several colleagues from the Office of Policy and Analysis offered helpful advice on various parts of the study. Carole M. P. Neves Director Office of Policy and Analysis PART I. BACKGROUND Fifty years ago, Nobel Prize winners Francis Crick and James Watson first visualized the three-dimensional molecular structure of deoxyribonucleic acid’s (DNA) double helix. Since they accomplished that extraordinary feat, scientists have made remarkable progress in the field of modern genomics, including sequencing the human genome.1 The traveling exhibition, Genome: The Secret of How Life Works, sponsored by Pfizer and produced by Clear Channel Entertainment-Exhibition, opened for display in a 5,000- square foot gallery in the Smithsonian Institution’s Arts and Industries Building (A&I Building) on June 6, 2003.
    [Show full text]
  • The Economic Impact and Functional Applications of Human Genetics and Genomics
    The Economic Impact and Functional Applications of Human Genetics and Genomics Commissioned by the American Society of Human Genetics Produced by TEConomy Partners, LLC. Report Authors: Simon Tripp and Martin Grueber May 2021 TEConomy Partners, LLC (TEConomy) endeavors at all times to produce work of the highest quality, consistent with our contract commitments. However, because of the research and/or experimental nature of this work, the client undertakes the sole responsibility for the consequence of any use or misuse of, or inability to use, any information or result obtained from TEConomy, and TEConomy, its partners, or employees have no legal liability for the accuracy, adequacy, or efficacy thereof. Acknowledgements ASHG and the project authors wish to thank the following organizations for their generous support of this study. Invitae Corporation, San Francisco, CA Regeneron Pharmaceuticals, Inc., Tarrytown, NY The project authors express their sincere appreciation to the following indi- viduals who provided their advice and input to this project. ASHG Government and Public Advocacy Committee Lynn B. Jorde, PhD ASHG Government and Public Advocacy Committee (GPAC) Chair, President (2011) Professor and Chair of Human Genetics George and Dolores Eccles Institute of Human Genetics University of Utah School of Medicine Katrina Goddard, PhD ASHG GPAC Incoming Chair, Board of Directors (2018-2020) Distinguished Investigator, Associate Director, Science Programs Kaiser Permanente Northwest Melinda Aldrich, PhD, MPH Associate Professor, Department of Medicine, Division of Genetic Medicine Vanderbilt University Medical Center Wendy Chung, MD, PhD Professor of Pediatrics in Medicine and Director, Clinical Cancer Genetics Columbia University Mira Irons, MD Chief Health and Science Officer American Medical Association Peng Jin, PhD Professor and Chair, Department of Human Genetics Emory University Allison McCague, PhD Science Policy Analyst, Policy and Program Analysis Branch National Human Genome Research Institute Rebecca Meyer-Schuman, MS Human Genetics Ph.D.
    [Show full text]
  • Genomic Sequencing of SARS-Cov-2: a Guide to Implementation for Maximum Impact on Public Health
    Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health ISBN 978-92-4-001844-0 (electronic version) ISBN 978-92-4-001845-7 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
    [Show full text]